1. The plasma clearance of intravenously injected 'l25-labelled mitochondrial malate dehydrogenase (half-life 7 min) was not influenced by previous injection of suramin and/or leupeptin (inhibitors of intralysosomal proteolysis). 2. Pretreatment with both inhibitors considerably delayed degradation of endocytosed enzyme in liver, spleen, bone marrow and kidneys. 3. The tissue distribution of radioactivity was determined at 30min after injection, when only 3% of the dose was left in plasma. All injected radioactivity was still present in the carcass. The major part of the injected dose was found in liver (49%), spleen (5%), kidneys (13%) and bone, including marrow (11%). 4 . Liver cells were isolated 15 min after injection of labelled enzyme. We found that Kupffer cells and parenchymal cells had endocytosed the enzyme at rates corresponding to 9530 and 156 ml of plasma/day per g of cell protein respectively. Endothelial cells do not significantly contribute to uptake of the enzyme. 5. Uptake by Kupffer cells was saturable, whereas uptake by parenchymal cells was not. This suggests that these cell types endocytose the enzyme via different receptors. 6. Previous injection of carbon particles greatly decreased uptake of the enzyme by liver, spleen and bone marrow.
Mitochondrial malate dehydrogenase (EC 1.1.1.37) is cleared very quickly from rat plasma after intravenous injection. In our previous paper (Bijsterbosch et al., 1981 a) we have shown that injected '25l-labelled mitochondrial malate dehydrogenase is rapidly endocytosed and subsequently degraded by liver, spleen, bone (marrow) and kidneys. Differential fractionation of liver provided evidence that breakdown of the endocytosed enzyme took place in the lysosomes. The rapid loss from the tissues of labelled products arising from intralysosomal proteolysis complicated quantitative assessment of the role of these tissues in plasma clearance of the enzyme. In the previous paper (Bijsterbosch et al., 1981a) we circumvented this difficulty by extrapolating from measurements of tissue radioactivity made within 10min after injection, when breakdown is still negligible. This method may, however, have been biased by the presence in the tissues of extracellular label, since plasma still contains a rather high concentration of labelled enzyme at 10min after injection. In addition, proteolysis and loss of label during isolation procedures precluded evaluation of the contribution of various types of liver cells to endocytosis of the enzyme.
It has been shown that these difficulties can largely be overcome by using sucrose-containing labels which do not readily escape from lysosomes (Pittman et al., 1979; Van Zile et al., 1979; De Jong et al., 1981) . Since these labels were not available at the start of our experiments on mitochondrial malate dehydrogenase, we have used another approach, namely inhibition of intralysosomal proteolysis by leupeptin and suramin. In vivo, as well as in perfused liver, leupeptin, a modified tripeptide isolated from actinomycetes (Umezawa, 1972) , considerably delays degradation of endocytosed asialofetuin (Dunn et al., 1979) . Suramin, a trypanocidal drug. has been used successfully to inhibit in vivo the degradation of endocytosed lactate dehydrogenase M4 and formaldehyde-treated albumin (Buys et al.. 1973; Sinke et al., 1979) .
In the present paper we show that breakdown in vivo of endocytosed l25l-labelled mitochondrial malate dehydrogenase is also considerably delayed by prior injection of animals with leupeptin and suramin. The ensuing retention of radioactivity in the cells enabled us to determine the contribution of various tissues and of different liver cell types towards the clearance of the enzyme. 
Experimental

Handling ofanimals
Male rats of an inbred Wistar strain, weighing between 160 and 250g, were used. All experiments were done with anaesthetized animals. Anaesthesia was induced and maintained with Fluothane in a mixture of N20 and 02.
Suramin and leupeptin, dissolved in phosphatebuffered saline (6 mM-sodium phosphate buffer, pH7.35, containing 0.15 M-NaCl), were administered by injection into a lateral tail vein. The animals were injected with 2ml of solution, containing 250mg of suramin or 20mg of leupeptin, per kg body wt. Dog intestinal alkaline phosphatase was administered by injecting 0.5 ml of phosphatebuffered saline, containing about 20 units of the enzyme, into the penile vein. Rats were carbonloaded by injecting, via a lateral tail vein, 4ml of phosphate-buffered saline, containing 370mg of carbon particles, per kg body wt.
Injection of labelled enzyme and handling of blood samples, liver, spleen, bone (marrow) and kidneys were done as described previously (Bijsterbosch et al., 198 la) . Small intestine, muscle and skin were dissolved in 50, 150 and 150ml, respectively, of 10.5M-NaOH at 900C for 2h. All other tissues were dissolved together in 100ml of 10.5M-NaOH. Samples of the resulting solutions were counted for radioactivity. Isolation ofparenchymal and sinusoidal liver cells Liver was first perfused from the portal vein without recirculation with 300 ml of Ca2+-free Hanks balanced salt solution (Hanks & Wallace, 1949) at 370C at a flow rate of 20ml/min per I00g body wt. Then 100ml of Hanks medium, containing 0.04% (w/v) collagenase and 2% (w/v) bovine serum albumin, was recirculated through the isolated liver in vitro for 3-4min at the same temperature and the same rate. The perfusion medium was gassed with 02/CO2 (19:1). The tissue was gently suspended in the same medium, incubated for another 10-15 min under gentle shaking at 37°C and subsequently filtered through nylon gauze (110 mesh). Parenchymal cells were purified by centrifugation of the cell suspension at 0-40C for 2 min at 45g. The sediment was washed with 3 x 40 ml of the same medium. About 30% of the parenchymal cells originally present in liver were recovered. The viability of these cells, as determined by the nigrosin exclusion test , was at least 90%. The cells were not contaminated with non-parenchymal cells or cell fragments as judged by light microscopy. Sinusoidal cells were prepared by centrifuging the supernatants obtained after sedimentation of the parenchymal cells for 5min at 560 g and at 0-40C. The pellet, which consisted mainly of non-parenchymal cells. was washed twice with the same medium. This cell preparation was freed from erythrocytes and residual parenchymal cells by isopycnic centrifugation in a Metrizamide solution as described by Knook & Sleyster (1976) . The recovery of sinusoidal cells, corrected for the presence of some (membrane-enclosed) parenchymal-cell debris as described by Van Berkel & Van Tol (1978) was about 10% ; the viability was at least 90%.
Sinusoidal cells were also prepared by Pronase treatment of liver at 100C and thereafter separated into Kupffer cells and endothelial cells as described by Praaning-Van Dalen & Knook (1982) .
Assay ofalkaline phosphatase activity
Alkaline phosphatase activity was measured as described by Friedel et al. (1975) .
Other methods
Protein labelling, assay of radioactivity and determination of proteins were done as described previously (Bijsterbosch et al., 1981 a suppression of fusion of lysosomes and endosomes (D'Arcy Hart & Young, 1975) . Furthermore, the inhibitors probably differ in the extent to which they penetrate target cells. In liver, for instance, suramin accumulates after intravenous injection in sinusoidal cells, but not in parenchymal cells (Buys et al., 1973) , and will therefore not affect degradation of endocytosed protein in the latter cells. Leupeptin, on the other hand, in vivo inhibits intralysosomal proteolysis in sinusoidal cells (J. Sinke, unpublished work) as well as in parenchymal cells (Dunn et al., 1979) .
Tissue distribution of '25I-labelled mitochondrial malate dehvdrogenase In our previous paper (Bijsterbosch et al., 198 la), we calculated that of injected mitochondrial malate dehydrogenase 85-90% was taken up and subsequently broken down by liver, spleen, bone and kidneys. We arrived at this value by extrapolating from data on uptake of the enzyme by the tissues obtained within 10min after injection, i.e. before the loss of labelled breakdown products started. At this time at least 35% of the dose was still circulating. The retention of radioactivity in the tissues of animals pretreated with the suramin/leupeptin combination allowed a direct assay of the tissue distribution of the labelled enzyme. We did this 30min after injection, when the enzyme has almost completely been cleared from plasma. Table 2 shows that liver, spleen, bone (marrow) and kidneys are indeed mainly responsible for the clearance of the enzyme. The present data are very similar to our previous estimates (Bijsterbosch et al., 1981 a) , thus adding credibility to the methods used. About 18% of the enzyme was present in small intestine, muscle, skin and 'other tissues'. This might reflect leakage of the enzyme (mol.wt. 67000) to extravascular spaces and uptake by peripheral macrophages.
The presence of acid-soluble radioactivity in plasma indicates that some breakdown has occurred. However, the complete recovery of the injected dose shows that little or no radioactivity is lost from the animals. As outlined in the introduction, labelling of proteins with a sucrose-containing label is for this type of study preferable to labelling with 1251. However, our results indicate that, if tagging with a sucrose-containing label is not possible, 251I-labelled proteins can be used, provided that the animals are pretreated with inhibitors of lysosomal proteolysis and that the proteins are relatively short-lived (half-lives of a few hours or less).
Distribution of endocytosed 125I-labelled mitochondrial malate dehydrogenase between liver cell types
The bulk of the liver mass consists of relatively big parenchymal cells. Liver cells that are situated along the blood sinusoids (mainly Kupffer cells and endothelial cells) are called sinusoidal cells. As is clear from previous work (Munniksma et al., 1980; Praaning-Van Dalen et al., 1981) , parenchymal, Kupffer and endothelial cells are actively endocytosing cells. It was therefore decided to determine which cell types are involved in the uptake of mitochondrial malate dehydrogenase by liver. Parenchymal and sinusoidal liver cells were isolated (Bijsterbosch et al., 198 la) 59.1 +4.9 (14) 4.5 +0.5 (14) 11.4 +0.6 (4) 13.4 +0.9 (14) after injection of labelled enzyme into rats that had been pretreated with suramin and leupeptin. In a separate series of experiments, Kupffer and endothelial cells were purified by centrifugal elutriation after perfusion of livers with Pronase as described by Praaning-Van Dalen & Knook (1982) . The results are summarized in Table 3 . The most striking results are the large differences between the endocytotic index of Kupffer cells and those of parenchymal and endothelial cells. These quantitative findings are in good agreement with the impression given by radioautograms (Bijsterbosch et al., 198 la) . If stereological data on the number of parenchymal, endothelial and Kupffer cells in rat liver (Blouin et al., 1977) are used, and if it is assumed that the protein concentration in each cell type is the same, it is easy to calculate that Kupffer cells contribute about 60% to the uptake by liver. Parenchymal cells are responsible for the remaining 40%, for the contribution of endothelial cells is virtually nil. It should be noted that the radioactivity in the parenchymal-cell fraction might partly be due to contamination with Kupffer cells (De Jong et al., 1982) , so that the actual contribution of the Kupffer cells might be even greater.
For the following reasons, we think it safe to presume that our results have not been biased by extensive degradation and subsequent loss of label during the isolation procedures. Isolation of parenchymal and sinusoidal cell fractions was mainly performed at 0-40C, where degradation is much diminished. Perfusions and incubation with collagenase, which were done at 370C, took at most 30 min. This is a relatively short period in view of the Table 3 . Rates of endocytosis of '25I-labelled mitochondrial malate dehydrogenase by liver and various liver cell types Rats were injected with suramin, leupeptin and labelled enzyme as described in the legend to Table  2 . Cells were isolated 15 min after injection of the enzyme. Endocytotic indices were calculated as described by De Jong et al. (1982) , by using a rate constant for plasma clearance of 0.104 min-'. Bijsterbosch et al., 198 la). slow loss of radioactivity from liver in vivo (see Fig.  la) . Purification of Kupffer and endothelial cells was even entirely done at low temperature. Besides, summation of the contributions of individual cell types, calculated by use of data of Blouin et al. (1977) , yielded an endocytotic index for whole liver of about 400ml of plasma cleared of the enzyme/ day per g of tissue protein, which is close to the value of 487 ml that was actually measured.
In our previous paper (Bijsterbosch et al., 1981a) , we showed that mitochondrial malate dehydrogenase is taken up in liver, spleen and bone marrow via receptors that can be saturated by injecting a high dose of the enzyme. We wondered whether saturation occurs in both parenchymal and sinusoidal liver cells, or is restricted to one of these cell types. Table 4 shows that uptake by sinusoidal cells, i.e. Kupffer cells, can be saturated, whereas uptake by parenchymal cells was not significantly lowered. The slight, statistically not significant, decrease in uptake by the parenchymal-cell fraction might, however, be due to saturation phenomena in contaminating Kupffer cells. The difference in uptake kinetics between sinusoidal and parenchymal cell fractions proves that the uptake by the latter is not entirely due to contamination with Kupffer cells. Taken together, these findings suggest that Kupffer cells and parenchymal cells endocytose the enzyme via different receptors.
Uptake of l2II-labelled mitochondrial malate dehydrogenase in carbon-loaded rats To obtain corroborative evidence for the important role of the reticuloendothelial system in removal of mitochondrial malate dehydrogenase from blood, we have studied plasma clearance and tissue uptake of the enzyme in carbon-loaded rats. The results are shown in Table 5 . Uptake of the enzyme by liver, spleen and bone marrow was substantially decreased by previous injection of carbon particles, whereas uptake by kidneys was unaffected. Carbon loading presumably has no effect on uptake of the enzyme by parenchymal liver cells. Plasma clearance of dog intestinal alkaline phosphatase, a glycoprotein with terminal galactose residues that is endocytosed by parenchymal liver cells (Scholtens, 1980) , was unaffected by carbon loading: half-lives in carbon-loaded and control rats were 2.5 + 0.1 min and 2.8 + 0.3 min (means + S.E.M.; three rats) respectively. Therefore, if carbon loading blocks uptake by Kupffer cells completely, the data in Table 5 indicate that 75-80% of the enzyme is taken up in liver by Kupffer cells.
Injection of carbon-loaded rats with a higher dose of the enzyme (4 mg instead of 1 mg of enzyme per kg body wt.) resulted in a rate of uptake by liver corresponding to 98 + 8 ml of plasma cleared of enzyme/day per g of tissue protein (mean + S.E.M.;
Vol. 208 Table 5 . Effect ofcarbon loading on clearance and uptake of'25I-labelled mitochondrial malate dehvdrogenase Rats were injected with carbon particles (370mg/kg body wt.) 4h before injection of labelled enzyme (1 mg/kg body wt.). Control animals were not previously injected. Clearance of acid-precipitable radioactivity was followed for 2-3 half-lives. Four blood samples per animal were taken for the calculation of clearance rates. Radioactivities in liver, spleen, bone marrow and kidneys were determined at 10min after injection of labelled enzyme. Endocytotic indices were calculated as described by De Jong et al. (1982) . Values are means + S.E.M. for the numbers of rats given in parentheses. Differences were tested for significance by Wilcoxon's two-sample test (one-sided; Wilcoxon, 1945 Table 5 ).
Since in carbon-loaded livers the enzyme is probably principally taken up by parenchymal cells, these findings indicate that parenchymal-cell receptors for the enzyme are not saturated at this dose, which is in good agreement with the results from Table 4 .
General discussion Our findings on mitochondrial malate dehydrogenase are very similar to those on lactate dehydrogenase M4 (De Jong et al., 1982) . Both enzymes are taken up mainly by liver, spleen and bone (marrow). In liver uptake occurs in Kupffer cells and to a small degree in parenchymal cells. Endothelial cells, which endocytose a variety of substances very actively (see De Jong et al., 1982) . presumably lack the receptors for both enzymes. The nature of the receptors on Kupffer cells is still unknown, but preliminary competition experiments suggest that both enzymes are taken up via the same receptors.
